New heart valve passes safety check in 57 patients
NCT ID NCT02987387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the SAPIEN XT heart valve, which is placed through a thin tube (catheter) to fix a failed valve in the heart's right ventricle. Researchers wanted to confirm it is safe and works well. They enrolled 57 people with a narrowed or leaky heart valve conduit. The main goal was to see if the valve prevented death or the need for another procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SAPIEN XT Transcatheter Heart Valve (a replacement heart valve delivered through a catheter)
What this could lead to
If successful, this confirms a less invasive option for replacing a failed heart valve conduit, reducing the need for open-heart surgery.
What could go wrong
This is a post-approval study with a small number of participants (57), so results may not apply to all patients. Risks include bleeding, infection, or the valve not working as intended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Children's Hospital
Oak Lawn, Illinois, 60453, United States
-
Children's Heart Center Nevada
Las Vegas, Nevada, 89109, United States
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Mount Sinai Beth Israel
New York, New York, 10003, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
Newark Beth Israel Medical Center
Newark, New Jersey, 07112, United States
-
The University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Alabama
Birmingham, Alabama, 35294, United States